Source: Le J. Pediatr Infect Dis J. 2013;doi:10.1097/INF.0b013e318286378e.
February 15, 2013
1 min read
Save

Consider age, MRSA patterns before selecting vacomycin for children

Source: Le J. Pediatr Infect Dis J. 2013;doi:10.1097/INF.0b013e318286378e.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Vancomycin dosages ranging from 60 mg/kg to 70 mg/kg per day were necessary to achieve optimal drug exposure needed to treat serious infections in children, according to results of a new study.

In addition, targeted use of this medication by area under the curve/minimum inhibitory concentrations (AUC/MIC), as opposed to trough concentration, may be necessary to achieve optimal dosages, according to Jennifer Le, PharmD, MAS, FCCP, BCPS-ID, and colleagues at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences.

Jennifer Le, PharmD 

Jennifer Le

The researchers analyzed modeling data on 702 children aged older than 3 months who received vancomycin between 2003 and 2011. This is the largest study to-date to evaluate vancomycin pharmacokinetics in hospitalized children.

Monte Carlo simulation indicated that the initial median dose of 44 mg/kg/day (range: 39 mg/kg/day to 52 mg/kg/day) was inadequate in most children. Regimens of 60 mg/kg/day for patients aged 12 years and older and 70 mg/kg/day for those aged younger than 12 years achieved target AUC/MIC in about 75% of virtual patients and trough concentrations of ≥15 mcg/mL in about 45% of virtual patients, according to the findings.

Le and colleagues noted that their data demonstrated the importance of considering age, kidney function and local methicillin-resistant Staphylococcus aureus susceptibility patterns before deciding on a vancomycin regimen for children.

Jennifer Le, PharmD, MAS, FCCP, BCPS-ID, can be reached at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, 9500 Gilman Drive, MC 0714 La Jolla, CA 92093-0714; email: jenle@ucsd.edu.

Disclosure:Le reports no relevant financial disclosures.